U.S. Markets closed

Kelyniam Global, Inc. (KLYG)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1400-0.0005 (-0.36%)
At close: 12:06PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1405
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1400 - 0.1500
52 Week Range0.0800 - 0.9000
Avg. Volume103,996
Market Cap1.794M
Beta (5Y Monthly)-1.75
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateApr 02, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Kelyniam Global Receives U.S. Patent for Integrated Fixation Tabs

    Kelyniam Global, a leader in the design and manufacture of custom cranial implants, is pleased to announce that the United States Patent and Trademark Office has issued the company an Issue Notification for a patent covering the company's Integrated Fixation Tabs, currently marketed as IFS Tabs or KwikTabs. The US patent covers the integration of fixation appendages into a cranial implant and their design. The patent was filed in 2014 and will run through 2037.

  • PR Newswire

    Kelyniam Global Releases 3rd Quarter 2021 Financials

    Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its third quarter ended September 30, 2021.

  • PR Newswire

    Kelyniam Global, Inc. OTC Trading & Business Matters Update

    Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, is pleased to announce that the company has submitted all of the documentation required for establishment as a "Pink Current" filer under the new SEC Rule 15c2-11 ahead of schedule for the September 30, 2021 deadline. The submission of information to the OTCIQ portal and achieving "Pink Current" filing status is in keeping with Kelyniam's commitment to transparency and shareholder disclosure.